Selective Inhibition of Vascular Endothelial Growth Factor Receptor‐2 (VEGFR‐2) Identifies a Central Role for VEGFR‐2 in Human Aortic Endothelial Cell Responses to VEGF

References

• Yancopoulos G. D., Davis S., Gale N. W., Rudge J. S., Wiegand S. J., Holash J. Vascular‐specific growth factors and blood vessel formation. Nature 2000; 407(6801)242–248
   PubMed Web of Science ®Google Scholar
• Shalaby F., Rossant J., Yamaguchi T. P., Gertsenstein M., Wu X. F., Breitman M. L., Schuh A. C. Failure of blood‐island formation and vasculogenesis in Flk‐1‐deficient mice. Nature 1995; 376(6535)62–66
   PubMed Web of Science ®Google Scholar
• Fong G. H., Rossant J., Gertsenstein M., Breitman M. L. Role of the Flt‐1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376(6535)66–70
   PubMed Web of Science ®Google Scholar
• Kaipainen A., Korhonen J., Mustonen T., van Hinsbergh V. W., Fang G. H., Dumont D., Breitman M., Alitalo K. Expression of the fms‐like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995; 92(8)3566–3570
   PubMed Web of Science ®Google Scholar
• Bernatchez P. N., Soker S., Sirois M. G. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet‐activating factor synthesis is Flk‐1‐dependent. J Biol Chem 1999; 274(43)31047–31054
   Google Scholar
• Kroll J., Waltenberger J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 1997; 272(51)32521–32527
   Google Scholar
• Gille H., Kowalski J., Li B., LeCouter J., Moffat B., Zioncheck T. F., Pelletier N., Ferrara N. Analysis of biological effects and signaling properties of Flt‐1 (VEGFR‐1) and KDR (VEGFR‐2). A reassessment using novel receptor‐specific vascular endothelial growth factor mutants. J Biol Chem 2001; 276(5)3222–3230
   PubMed Web of Science ®Google Scholar
• Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410(6824)37–40
   PubMed Web of Science ®Google Scholar
• Rousseau S., Houle F., Landry J., Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 1997; 15(18)2169–2177
   PubMed Web of Science ®Google Scholar
• Takahashi T., Yamaguchi S., Chida K., Shibuya M. A single autophosphorylation site on KDR/Flk‐1 is essential for VEGF‐A‐dependent activation of PLC‐gamma and DNA synthesis in vascular endothelial cells. EMBO J 2001; 20(11)2768–2778
   PubMed Web of Science ®Google Scholar
• Morales‐Ruiz M., Fulton D., Sowa G., Languino L. R., Fujio Y., Walsh K., Sessa W. C. Vascular endothelial growth factor‐stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res 2000; 86(8)892–896
   Google Scholar
• Gerber H. P., McMurtrey A., Kowalski J., Yan M., Keyt B. A., Dixit V., Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′‐kinase/Akt signal transduction pathway. Requirement for Flk‐1/KDR activation. J Biol Chem 1998; 273(46)30336–30343
   PubMed Web of Science ®Google Scholar
• Shiojima I., Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 2002; 90(12)1243–1250
   PubMed Web of Science ®Google Scholar
• Lee M. J., Thangada S., Paik J. H., Sapkota G. P., Ancellin N., Chae S. S., Wu M., Morales‐Ruiz M., Sessa W. C., Alessi D. R., Hla T. Akt‐mediated phosphorylation of the G protein‐coupled receptor EDG‐1 is required for endothelial cell chemotaxis. Mol Cell 2001; 8(3)693–704
   Web of Science ®Google Scholar
• Bar‐Sagi D., Hall A. Ras and Rho GTPases: a family reunion. Cell 2000; 103(2)227–238
   PubMed Web of Science ®Google Scholar
• Kiyokawa E., Mochizuki N., Kurata T., Matsuda M. Role of Crk oncogene product in physiologic signaling. Crit Rev Oncog 1997; 8(4)329–342
   Google Scholar
• Kiyokawa E., Hashimoto Y., Kobayashi S., Sugimura H., Kurata T., Matsuda M. Activation of Rac1 by a Crk SH3‐binding protein, DOCK180. Genes Dev 1998; 12(21)3331–3336
   Google Scholar
• Yano H., Uchida H., Iwasaki T., Mukai M., Akedo H., Nakamura K., Hashimoto S., Sabe H. Paxillin alpha and Crk‐associated substrate exert opposing effects on cell migration and contact inhibition of growth through tyrosine phosphorylation. Proc Natl Acad Sci USA 2000; 97(16)9076–9081
   Google Scholar
• Ito N., Wernstedt C., Engstrom U., Claesson‐Welsh L. Identification of vascular endothelial growth factor receptor‐1 tyrosine phosphorylation sites and binding of SH2 domain‐containing molecules. J Biol Chem 1998; 273(36)23410–23418
   Google Scholar
• Stoletov K. V., Ratcliffe K. E., Spring S. C., Terman B. I. NCK and PAK participate in the signaling pathway by which vascular endothelial growth factor stimulates the assembly of focal adhesions. J Biol Chem 2001; 276(25)22748–22755
   Google Scholar
• Endo A., Nagashima K., Kurose H., Mochizuki S., Matsuda M., Mochizuki N. Sphingosine 1‐phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII. J Biol Chem 2002; 277(26)23747–23754
   Google Scholar
• Kim Y. M., Kim Y. M., Lee Y. M., Kim H. S., Kim J. D., Choi Y., Kim K. W., Lee S. Y., Kwon Y. G. TNF‐related activation‐induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J Biol Chem 2002; 277(9)6799–6805
   Google Scholar
• Hennequin L. F., Thomas A. P., Johnstone C., Stokes E. S., Plé P. A., Lohmann J. J., Ogilvie D. J., Dukes M., Wedge S. R., Curwen J. O., Kendrew J., Lambert‐van der Brempt C. Design and structure‐activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors. J Med Chem 1999; 42(26)5369–5389
   PubMed Web of Science ®Google Scholar
• Whittles C. E., Pocock T. M., Wedge S. R., Kendrew J., Hennequin L. F., Harper S. J., Bates D. O. ZM323881, a novel inhibitor of vascular endothelial growth factor‐receptor‐2 tyrosine kinase activity. Microcirculation 2002; 9(6)513–522
   Google Scholar
• Ferrara N., Davis‐Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18(1)4–25
   PubMed Web of Science ®Google Scholar
• Shibuya M. Structure and function of VEGF/VEGF‐receptor system involved in angiogenesis. Cell Struct Funct 2001; 26(1)25–35
   PubMed Web of Science ®Google Scholar
• Lauffenburger D. A., Horwitz A. F. Cell migration: a physically integrated molecular process. Cell 1996; 84(3)359–369
   PubMed Web of Science ®Google Scholar
• Bishop A. L., Hall A. Rho GTPases and their effector proteins. Biochem J 2000; 348(Pt 2)241–255
   PubMed Web of Science ®Google Scholar
• Toker A., Cantley L. C. Signalling through the lipid products of phosphoinositide‐3‐OH kinase. Nature 1997; 387(6634)673–676
   PubMedGoogle Scholar
• Thakker G. D., Hajjar D. P., Muller W. A., Rosengart T. K. The role of phosphatidylinositol 3‐kinase in vascular endothelial growth factor signaling. J Biol Chem 1999; 274(15)10002–10007
   Google Scholar
• Makinen T., Veikkola T., Mustjoki S., Karpanen T., Catimel B., Nice E. C., Wise L., Mercer A., Kowalski H., Kerjaschki D., Stacker S. A., Achen M. G., Alitalo K. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3. EMBO J 2001; 20(17)4762–4773
   PubMed Web of Science ®Google Scholar
• Nagashima K., Endo A., Ogita H., Kawana A., Yamagishi A., Kitabatake A., Matsuda M., Mochizuki N. Adaptor protein Crk is required for ephrin‐B1‐induced membrane ruffling and focal complex assembly of human aortic endothelial cells. Mol Biol Cell 2002; 13(12)4231–4242
   PubMed Web of Science ®Google Scholar
• Klemke R. L., Cai S., Giannini A. L., Gallagher P. J., de Lanerolle P., Cheresh D. A. Regulation of cell motility by mitogen‐activated protein kinase. J Cell Biol 1997; 137(2)481–492
   PubMedGoogle Scholar
• Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., DiPalma T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K. H., Foidart J. M., Schaper W., Charnock‐Jones D. S., Hicklin D. J., Herbert J. M., Collen D., Persico M. G. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7(5)575–583
   PubMed Web of Science ®Google Scholar
• Wang H., Keiser J. A. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt‐1. Circ Res 1998; 83(8)832–840
   PubMed Web of Science ®Google Scholar
• Lafleur M. A., Handsley M. M., Knauper V., Murphy G., Edwards D. R. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane‐type‐matrix metalloproteinases (MT‐MMPs). J Cell Sci 2002; 115(Pt17)3427–3438
   Google Scholar
• Huang K., Andersson C., Roomans G. M., Ito N., Claesson‐Welsh L. Signaling properties of VEGF receptor‐1and‐2 homo‐ and heterodimers. Int J Biochem Cell Biol 2001; 33(4)315–324
   PubMed Web of Science ®Google Scholar
• Kendall R. L., Wang G., Thomas K. A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT‐1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996; 226(2)324–328
   PubMed Web of Science ®Google Scholar
• Autiero M., Waltenberger J., Communi D., Kranz A., Moons L., Lambrechts D., Kroll J., Plaisance S., De Mol M., Bono F., Kliche S., Fellbrich G., Ballmer‐Hofer K., Maglione D., Mayr‐Beyrle U., Dewerchin M., Dombrowski S., Stanimirovic D., Van Hummelen P., Dehio C., Hicklin D. J., Persico G., Herbert J. M., Communi D., Shibuya M., Collen D., Conway E. M., Carmeliet P. Role of PlGF in the intra‐ and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003; 9(7)936–943
   PubMed Web of Science ®Google Scholar